Bambusa Therapeutics, Inc. (BBTX)

CIK 2044950 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bambusa Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G0002085929-26-000014
Nov 3, 202640001231919-26-001533
Nov 3, 20268-K0001628280-26-069027
Nov 2, 202640002162499-26-000004
Nov 2, 202640002160743-26-000012
Nov 2, 202640002160743-26-000013
Nov 2, 202640001982614-26-000004
Oct 30, 2026424B40001628280-26-068563
Oct 30, 2026S-80001628280-26-068355
Oct 29, 202630002162499-26-000002
Oct 29, 202630002160666-26-000002
Oct 29, 202630002159278-26-000002
Oct 29, 202630002160743-26-000009
Oct 29, 2026CERT0001354457-26-001035
Oct 29, 202630001663427-26-000003
Oct 29, 202630001792061-26-000002
Oct 29, 202630001350090-26-000003
Oct 29, 2026EFFECT9999999995-26-003375
Oct 29, 202630001231919-26-001513
Oct 29, 202630001982614-26-000002
Oct 29, 2026S-1MEF0001628280-26-068311
Oct 27, 20268-A12B0001628280-26-067557
Oct 26, 2026S-1/A0001628280-26-067119
Oct 9, 2026S-10001628280-26-065557
Feb 26, 2025D0002044950-25-000003